Veterinary medicines

EMA is responsible for the scientific evaluation, supervision and safety monitoring of veterinary medicines in the EU. In 2020, EMA recommended 20 veterinary medicines for marketing authorisation, including 13 with a new active substance. Ten were vaccines, more than double the number of vaccines authorised in the previous year. Of these, eight were biotechnological vaccines. Here are some key figures on the authorisation and safety monitoring of veterinary medicines in 2020. For more detailed information, download the full annual report 2020 (PDF version).